Linda Black is the founder of Gallant. Gallant has raised $50M in total funding. Latest round: Series B. Backed by Digitalis Ventures.
Dr. Linda Black is the Co-founder and CEO of Gallant, a veterinary biotechnology company that develops off-the-shelf stem cell therapies for pets. She has a DVM and PhD and is leading the company toward conditional FDA approval for its first investigational therapy for Feline Chronic Gingivostomatitis (FCGS).
Full founder directory · Investor directory · Company funding database · Fundraising library